|
| Status |
Public on Jan 15, 2020 |
| Title |
Sequencing of iMDK-treated regenerating limbs |
| Organism |
Ambystoma mexicanum |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Treatment with midkine inhibitor iMDK inhibits limb regeneration. To elucidate the transcriptional mechanisms of iMDK treatment, we sequenced regenerating limbs treated with either DMSO or iMDK (bulk) in biological triplicate at 11 days post-amputation (dpa).
|
| |
|
| Overall design |
Limbs were treated with iMDK or DMSO beginning immediately post-amputation up until the collection point at 11 dpa.
|
| |
|
| Contributor(s) |
Tsai SL, Melton DA |
| Citation(s) |
31934849 |
| |
| Submission date |
Jun 06, 2019 |
| Last update date |
Jan 15, 2020 |
| Contact name |
Douglas A. Melton |
| E-mail(s) |
dmelton@harvard.edu
|
| Organization name |
Harvard University
|
| Street address |
7 Divinity Ave.
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02138 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL24679 |
Illumina NextSeq 500 (Ambystoma mexicanum) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA547606 |
| SRA |
SRP200677 |
Less...
More...